您的位置: 首页 > 农业专利 > 详情页

METHOD FOR DIAGNOSING AND TREATING MULTIPLE MYELOMA
专利权人:
Erasmus University Medical Center Rotterdam;Skylinedx B.V.
发明人:
Martinus Hendrikus Van Vliet,Pieter Sonneveld
申请号:
US15128082
公开号:
US20170101684A1
申请日:
2015.03.28
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The disclosure is in the field of medical treatments and relates to the treatment of cancer, in particular, multiple myeloma (MM). Even more in particular, it provides means and methods for the improved treatment of certain subgroups of MM patients, more in particular, subjects with a poor prognosis. In a particular embodiment, the disclosure provides a method of treatment wherein subjects with a poor prognosis are selected and treated with a proteasome inhibitor such as Bortezomib. The disclosure further provides means and methods for identifying subjects with a poor prognosis. More in particular, the disclosure provides a composition comprising a proteasome inhibitor for use in the treatment of a subject with multiple myeloma when the subject has been diagnosed with an amp1q chromosomal aberration.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充